Dr. Mistry is a public health physician with wide ranging experience in HIV/AIDS and neglected tropical diseases having served as the Managing Director of the Global Network for Neglected Tropical Diseases. He brings extensive global health policy and programming experience having worked in both the public and private sectors, in clinical practice, health policy, and social development. Prior to accepting a position teaching at Georgetown University, he was engaged by the National Health Service in London, and with Merck & Co.

Tiffany Mensah is a public health educator and Program Coordinator at the Fatty Liver Foundation (FLF). In this role, she develops campaigns that promote behavior change and empower patients through accessible resources.<br><br>Before joining FLF, Tiffany worked as a Quality Assurance Analyst at Epic Systems, where she managed the development of infrastructure projects supporting a population health analytics application.

I am a nurse practitioner with Hepatology and Gastroenterology at University of North Carolina at Chapel Hill. I focus on inpatient care of patients with liver disease. I have been in my role since 2009, and help to educate residents, medical students and APP students on the care of liver patients. (sorry, I don't currently have a head shot, so just putting a nice picture of some trees. I'll try and get a headshot)

Jessica Wisocky is an accomplished Nurse Practitioner who has dedicated her career to caring for underserved and marginalized communities. She holds a Master of Science in Nursing from Simmons College and a Bachelor of Science from the University of New Hampshire with a double major of Biochemistry and Women's Studies and minor of Race/Power/Culture. <br><br>Jess was a recipient of the 2014 AASLD NP Hepatology Fellowship. She completed the Fellowship under the guidance of Dr. Ray Chung at Massachusetts General Hospital.

Dr. Cecilia Dueñas is a bilingual Spanish/English Latina Clinical Psychologist, mother of two, and wife based in Southern California. Diagnosed with Primary Biliary Cholangitis (PBC) in 2021 after more than six years of undiagnosed symptoms and healthcare inequities, she turned her personal journey into a mission to advocate for patients facing rare liver diseases and health disparities.

Jon advocates for those living with liver disease as a result of Alcohol Use Disorder. More specifically, his focus is on those who suffer from ACLF of which he is a thankful survivor because of transplant. He also advocates for LatinX and LGTBQ communities who may become marginalized by liver disease because of its stigma. Jon is a semi-retired Fintech executive who takes great pride in being both a plant and dog dad.

Dr. Norah Terrault is a transplant hepatologist, the Neil Kaplowitz Professor of Medicine and Chief of Gastrointestinal and Liver Diseases Division at the Keck School of Medicine of University of Southern California in Los Angeles, California.<br><br>Dr. Terrault has focused her clinical and research activities on viral hepatitis and fatty liver disease, with specific focus on patients with cirrhosis and liver transplant recipients. In addition to multiple clinical trials related to preventing and treating chronic hepatitis viral hepatitis and fatty liver, Dr.

Lorrinda Gray-Davis is a liver transplant recipient, author, and President of Transplant Recipients International Organization (TRIO). She serves as Vice Chair of the OPTN Patient Affairs Committee and is a passionate advocate for transplant equity. Her story was recently featured in Cancer Today magazine.

Dr. Singal is a Professor of Medicine at UT Southwestern Medical Center and serves as Chief of Hepatology and Medical Director of the Liver Tumor Program. He has over 300 peer-reviewed original publications and has been awarded the Willis Maddrey Distinguished Chair in Liver Disease and Blue Faery Award for Excellence in Liver Cancer Research.

Ming-Lung Yu is a Chair Professor of Kaohsiung Medical University (KMU), Taiwan. He is also an adjunct chair professor of National Sun Yat-sen University(NSYSU). Professor Yu's research interests in the Hepatology, including epidemiology, natural course, risk stratification, treatment and prognosis of HBV and HCV, as well as MASLD, have led him to publish more than 500 scientific original and review articles.